Controlled Study in Cranioplasty Reconstruction
Multicenter Prospective Controlled Study in Cranioplasty Reconstruction
1 other identifier
observational
91
0 countries
N/A
Brief Summary
Multicenter, prospective, comparative, observational study with regular follow-up visits. The project's aim is long-term follow-up of patients affected by large and complex craniolacuniae treated, in standard clinical practice, with CustomBone Service™ Cranial (porous bio-mimetic hydroxyapatite custom-made medical device for cranioplasty), autologous bone or polymethilmethacrylate customized prosthesis and to compare the clinical outcome and safety among the three treatments. Elegibility to each treatment will respect the standard clinical practice. Each investigator will respect his own hospital criteria for cranial reconstruction. Each centre's agreement to participate the study is totally voluntary. The study sample size has not been defined on statistical criteria: the study population was set at 100 consecutive patients treated with cranioplasty reconstruction with one of the three foreseen group. Each investigator will not be allowed to enrol more then 20 patients to avoid an enrolment imbalance between centres involved. Primary study end-points are: evaluation of adverse event incidence after surgical treatment. Secondary end-points are: quality of life improvement, evaluation of bone continuity restoration evaluated by CT scan analysis, neurological improvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2007
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 5, 2012
CompletedFirst Posted
Study publicly available on registry
July 16, 2012
CompletedAugust 19, 2015
August 1, 2015
Same day
July 5, 2012
August 18, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Safety
incidence of adverse event (infection, reabsorption, mobilization, fractures, dislocation) after surgical treatment
360 day after surgery
Secondary Outcomes (1)
Efficacy
90, 180, 360, 720 days after the surgery
Study Arms (3)
Hydroxyapatite Cranioplasty
patient underwent to cranioplasty reconstruction with customized hydroxyapatite prosthesis
polymethylmethacrylate
patient underwent to cranioplasty reconstruction with polymethylmethacrylate prosthesis
autologous bone
patients underwent to cranioplasty reconstruction by autologous bone repositioning
Interventions
customized hydroxyapatite cranial prosthesis
Eligibility Criteria
consecutive patients,in different italian centres, requiring cranioplasty
You may qualify if:
- Patients which need cranial reconstruction,
- Cranioplasty reconstruction by autologous bone, hidroxyapatite or polymethylmethacrylate,
- Patients of both sex in age range between 14 and 75 years old,
- Craniolacuniae size \> 25 cm2 ,
- Patients affected by complex pathologies or fracture or infection of a previous implant.
- Elegibility to CustomBone Service™ Cranial treatment will respect the product leaflet instructions.
You may not qualify if:
- Patients affected by important emocoagulation pathologies,
- Patients affected by mellitus diabetes,
- Patients affected by autoimmune pathology,
- Patients unable to intend,
- Patients affected by immunodepression.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY DIRECTOR
Franco Servadei, Prof. MD
Maggiore Hospital Parma
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Franco Servadei, Prof. MD
Study Record Dates
First Submitted
July 5, 2012
First Posted
July 16, 2012
Study Start
January 1, 2007
Primary Completion
January 1, 2007
Study Completion
September 1, 2011
Last Updated
August 19, 2015
Record last verified: 2015-08